RT Journal Article
T1 Recent Advances in Allergen-Specific Immunotherapy as Treatment for Allergic Asthma: A Practical Overview.
A1 Tabar, Ana I
A1 Delgado, Julio
A1 González-Mancebo, Eloina
A1 Arroabarren, Esozia
A1 Soto Retes, Lorena
A1 Domínguez-Ortega, Javier
A1 Spanish Allergy and Clinical Immunology Scientific Society (SEAIC), 
K1 Allergy
K1 Asthma
K1 Clinical practice
K1 Immunotherapy
AB The Global Initiative for Asthma Report updated in 2019 stated that potential benefits of allergen immunotherapy (AIT), compared to pharmacological and avoidance options, must be weighed against the risk of adverse effects and the inconvenience and cost of the prolonged course of therapy in asthma. Thus, with the aim of clarifying some aspects with regard to the possible use of AIT in allergic asthma treatment armamentarium, a group of expert allergists from the Spanish Allergy and Clinical Immunology Scientific Society (SEAIC), particularly from the Immunotherapy and Asthma Interest Groups developed a frequently asked questions in clinical practice. This document updates relevant topics on the use of AIT in asthma and could facilitate physician clinical decisions and improve health outcomes for individual patients.
YR 2021
FD 2021-02-25
LK http://hdl.handle.net/10668/17234
UL http://hdl.handle.net/10668/17234
LA en
DS RISalud
RD Apr 30, 2025